International Journal of Gerontology
Volume 1, Issue 2 , Pages 53-64 , June 2007

Non-motor Symptoms of Parkinson's Disease

  • Jyh-Gong Gabriel Hou

      Affiliations

    • Corresponding Author InformationCorrespondence to: Dr Jyh-Gong Gabriel Hou, Parkinson's Disease Research, Education and Clinical Center, Michael E. DeBakey VA Medical Center, Baylor College of Medicine, Houston, TX 77030, USA
    • ,
  • Eugene C Lai

,Accepted 30 March 2007.

References 

  1. Parkinson J . An essay on the shaking palsy . J Neuropsychiatry Clin Neurosci . 2002;14:223–236 Discussion, 222.
  2. Tanner CM , Aston DA . Epidemiology of Parkinson's disease and akinetic syndromes . Curr Opin Neurol . 2000;13:427–430
  3. Chaudhuri KR , Healy DG , Schapira AH . Non-motor symptoms of Parkinson's disease: diagnosis and management . Lancet Neurol . 2006;5:235–245
  4. Adler CH . Nonmotor complications in Parkinson's disease . Mov Disord . 2005;20(Suppl 11):S23–S29
  5. Habermann-Little B . An analysis of the prevalence and etiology of depression in Parkinson's disease . J Neurosci Nurs . 1991;23:165–169
  6. Kostic VS , Filipovic SR , Lecic D , Momcilovic D , Sokic D , Sternic N . Effect of age at onset on frequency of depression in Parkinson's disease . J Neurol Neurosurg Psychiatry . 1994;57:1265–1267
  7. Hantz P , Caradoc-Davies G , Caradoc-Davies T , Weatherall M , Dixon G . Depression in Parkinson's disease . Am J Psychiatry . 1994;151:1010–1014
  8. Pollock M , Hornabrook RW . The prevalence, natural history and dementia of Parkinson's disease . Brain . 1966;89:429–448
  9. Emre M . Dementia associated with Parkinson's disease . Lancet Neurol . 2003;2:229–237
  10. Rippon GA , Marder KS . Dementia in Parkinson's disease . Adv Neurol . 2005;96:95–113
  11. Schenck CH , Bundlie SR , Mahowald MW . Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder . Neurology . 1996;46:388–393
  12. Olson EJ , Boeve BF , Silber MH . Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases . Brain . 2000;123:331–339
  13. Magerkurth C , Schnitzer R , Braune S . Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life . Clin Auton Res . 2005;15:76–82
  14. Hobson P , Islam W , Roberts S , Adhiyman V , Meara J . The risk of bladder and autonomic dysfunction in a community cohort of Parkinson's disease patients and normal controls . Parkinsonism Relat Disord . 2003;10:67–71
  15. Visser M , Marinus J , Stiggelbout AM , Van Hilten JJ . Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT . Mov Disord . 2004;19:1306–1312
  16. Siddiqui MF , Rast S , Lynn MJ , Auchus AP , Pfeiffer RF . Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey . Parkinsonism Relat Disord . 2002;8:277–284
  17. Braune S , Reinhardt M , Schnitzer R , Riedel A , Lucking CH . Cardiac uptake of [123I] MIBG separates Parkinson's disease from multiple system atrophy . Neurology . 1999;53:1020–1025
  18. Taki J , Nakajima K , Hwang E-H , Matsunari I , Komai K , Yoshita M , et al.   Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific . Eur J Nucl Med . 2000;27:566–573
  19. Paulus W , Jellinger K . The neuropathologic basis of different clinical subgroups of Parkinson's disease . J Neuropathol Exp Neurol . 1991;50:743–755
  20. Brown AS , Gershon S . Dopamine and depression . J Neural Transm Gen Sect . 1993;91:75–109
  21. Middleton FA , Strick PL . Basal ganglia output and cognition: evidence from anatomical, behavioral, and clinical studies . Brain Cogn . 2000;42:183–200
  22. Clower DM , Dum RP , Strick PL . Basal ganglia and cerebellar inputs to ‘AIP’ . Cereb Cortex . 2005;15:913–920
  23. Benarroch EE . Central neurotransmitters and neuromodulators in cardiovascular regulation . In:  Mathias CJ ,  Bannister R editor. Autonomic Failure . 4th edition. Oxford: Oxford University Press; 1999;p. 37–44
  24. Goldstein DS , Holmes CS , Dendi R , Bruce SR , Li ST . Orthostatic hypotension from sympathetic denervation in Parkinson's disease . Neurology . 2002;58:1247–1255
  25. Dewey RB . Autonomic dysfunction in Parkinson's disease . Neurol Clin . 2004;22(3 Suppl):S127–S139
  26. Braak H , Del Tredici K , Bratzke H , Hamm-Clement J , Sandmann-Keil D , Rub U . Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages) . J Neurol . 2002;249(Suppl 3):III/1–III/5
  27. Braak H , Del Tredici K , Rub U , de Vos RAI , Jansen Steur ENH , Braak E . Staging of brain pathology related to sporadic Parkinson's disease . Neurobiol Aging . 2003;24:197–210
  28. Braak H , Ghebremedhin E , Rub U , Bratzke H , Del Tredici K . Stages in the development of Parkinson's disease-related pathology . Cell Tissue Res . 2004;318:121–134
  29. Doder M , Rabiner EA , Turjanski N , Lees AJ , Brooks DJ . Brain serotonin 5HT1A receptors in Parkinson's disease with and without depression measured by positron emission tomography with 11C-WAY 10635 . Mov Disord . 2000;15:213
  30. Mossner R , Henneberg A , Schmitt A , Syagailo YV , Grassle M , Hennig T , et al.   Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease . Mol Psychiatry . 2001;6:350–352
  31. Veazey C , Aki SO , Cook KF , Lai EC , Kunik ME . Prevalence and treatment of depression in Parkinson's disease . J Neuropsychiatry Clin Neurosci . 2005;17:310–323
  32. Henderson R , Kurlan R , Kersun JM , Como P . Preliminary examination of the comorbidity of anxiety and depression in Parkinson's disease . J Neuropsychiatry Clin Neurosci . 1992;4:257–264
  33. Slaughter JR , Slaughter KA , Nichols D , Holmes SE , Martens MP . Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease . J Neuropsychiatry Clin Neurosci . 2001;13:187–196
  34. Cummings JL . Depression and Parkinson's disease: a review . Am J Psychiatry . 1992;149:443–454
  35. Cole SA , Woodard JL , Juncos JL , Kogos JL , Youngstrom EA , Watts RL . Depression and disability in Parkinson's disease . J Neuropsychiatry Clin Neurosci . 1996;8:20–25
  36. Starkstein SE , Petracca G , Chemerinski E , Teson A , Sabe L , Merelllo M , et al.   Depression in classic versus akinetic-rigid Parkinson's disease . Mov Disord . 1998;13:29–33
  37. Schrag A , Jahanshahi M , Quinn NP . What contributes to depression in Parkinson's disease? . Psychol Med . 2001;31:65–73
  38. Richard IH , Kurlan R , Tanner C , Factor S , Hubble J , Suchowersky O , et al.   Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease. Parkinson Study Group . Neurology . 1997;48:1070–1077
  39. Weintraub D , Morales KH , Moberg PJ , Bilker WB , Balderston C , Duda JE , et al.   Antidepressant studies in Parkinson's disease: a review and meta-analysis . Mov Disord . 2005;20:1161–1169
  40. Aarsland D , Larsen JP , Waage O , Langeveld JH . Maintenance of electroconvulsive therapy for Parkinson's disease . Convuls Ther . 1997;13:274–277
  41. Moellentine C , Rummans T , Ahlskog JE , Harmsen WS , Suman VJ , O'Connor MK , et al.   Effectiveness of ECT in patients with parkinsonism . J Neuropsychiatry Clin Neurosci . 1998;10:187–193
  42. Menza MA , Robertson-Hoffman DE , Bonapace AS . Parkinson's disease and anxiety: comorbidity with depression . Biol Psychiatry . 1993;34:465–470
  43. Walsh K , Bennett G . Parkinson's disease and anxiety . Postgrad Med J . 2001;77:89–93
  44. Menza MA , Sage J , Marshall E , Cody R , Duvoisin R . Mood changes and “on-off” phenomena in Parkinson's disease . Mov Disord . 1990;5:148–151
  45. Menza M , Marin H , Kaufman K , Mark M , Lauritano M . Citalopram treatment of depression in Parkinson's disease: the impact on anxiety, disability, and cognition . J Neuropsychiatry Clin Neurosci . 2004;16:315–319
  46. Weintraub D , Stern MB . Psychiatric complications in Parkinson disease . Am J Geriatr Psychiatry . 2005;13:844–851
  47. Aarsland D , Andersen K , Larsen JP , Lolk A , KraghSorensen P . Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study . Arch Neurol . 2003;60:387–392
  48. Alexander GE , DeLong MR , Strick PL . Parallel organization of functionally segregated circuits linking basal ganglia and cortex . Annu Rev Neurosci . 1986;9:357–381
  49. Calabresi P , Picconi B , Parnetti L , Di Filippo M . A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance . Lancet Neurol . 2006;5:974–983
  50. Cooper B , Holmes C . Previous psychiatric history as a risk factor for late-life dementia: a population-based case-control study . Age Ageing . 1998;27:181–188
  51. Haugarvoll K , Aarsland D , Wentzel-Larsen T , Larsen JP . The influence of cerebrovascular risk factors on incident dementia in patients with Parkinson's disease . Acta Neurol Scand . 2005;112:386–390
  52. Pillon B , Boller F , Levy R , Dubois B . Cognitive deficits and dementia in Parkinson's disease . In:  Boller F ,  Cappa S editor. Aging and Dementia . Amsterdam: Elsevier; 2001;p. 311–372
  53. Bertrand E , Lechowicz W , Szpak GM , Lewandowska E , Dymecki J , Wierzba-Bobrowicz T . Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia . Folia Neuropathol . 2004;42:141–150
  54. Iseki E . Dementia with Lewy bodies: reclassification of pathological subtypes and boundary with Parkinson's disease or Alzheimer's disease . Neuropathology . 2004;24:72–78
  55. McKeith IG , Dickson DW , Lowe J , Emre M , O'Brien JT , Feldman H , et al.   Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium . Neurology . 2005;65:1863–1872
  56. McKeith IG , Ballard CG , Perry RH , Ince PG , O'Brien JT , Neill D , et al.   Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies . Neurology . 2000;54:1050–1058
  57. Emre M , Aarsland D , Albanese A , Byrne EJ , Deuschl G , De Deyn PP , et al.   Rivastigmine for dementia associated with Parkinson's disease . N Engl J Med . 2004;351:2509–2518
  58. Siddiqui MA , Wagstaff AJ . Rivastigmine: in Parkinson's disease dementia . CNS Drugs . 2006;20:739–747
  59. Boeve BF . Evidence for cholinesterase-inhibitor therapy for dementia associated with Parkinson's disease . Lancet Neurol . 2005;4:137–138
  60. Inzelberg R , Bonuccelli U , Schechtman E , Miniowich A , Strugatsky R , Ceravolo R , et al.   Association between amantadine and the onset of dementia in Parkinson's disease . Mov Disord . 2006;21:1375–1379
  61. Menendez-Gonzalez M , Calatayud MT , Blazquez-Menes B . Exacerbation of Lewy bodies dementia due to memantine . J Alzheimers Dis . 2005;8:289–291
  62. Diederich NJ , Goetz CG , Stebbins GT . Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model . Mov Disord . 2005;20:130–140
  63. Goetz CG , Stebbins GT . Mortality and hallucinations in nursing home patients with advanced Parkinson's disease . Neurology . 1995;45:669–671
  64. Chou KL , Messing S , Oakes D , Feldman PD , Breier A , Friedman JH . Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instruments . Clin Neuropharmacol . 2005;28:215–219
  65. Fenelon G , Mahieux F , Huon R , Ziegler M . Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors . Brain . 2000;123:733–745
  66. Aarsland D , Larsen JP , Karlsen K , Lim NG , Tandberg E . Mental symptoms in Parkinson's disease are important contributors to caregiver distress . Int J Geriatr Psychiatry . 1999;14:866–874
  67. Miyasaki JM , Shannon K , Voon V , Ravina B , KleinerFisman G , Anderson K , et al.   Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology . Neurology . 2006;66:996–1002
  68. Merims D , Balas M , Peretz C , Shabtai H , Giladi N . Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis . Clin Neuropharmacol . 2006;29:331–337
  69. Tariot PN , Schneider L , Katz IR , Mintzer JE , Street J , Copenhaver M , et al.   Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial . Am J Geriatr Psychiatry . 2006;14:767–776
  70. Yang SY , Kao Yang YH , Chong MY , Yang YH , Chang WH , Lai CS . risk of extrapyramidal syndrome in schizophrenic patients treated with antipsychotics: a population-based study . Clin Pharmacol Ther . 2007;81:586–594
  71. Frieling H , Hillemacher T , Ziegenbein M , Neundorfer B , Bleich S . Treating dopamimetic psychosis in Parkinson's disease: structured review and meta-analysis . Eur Neuropsychopharmacol . 2007;17:165–171
  72. Stacy M . Sleep disorders in Parkinson's disease: epidemiology and management . Drugs Aging . 2002;19:733–739
  73. Onofrj M , Thomas A , D'Andreamatteo G , Iacono D , Luciano AL , Di Rollo A , et al.   Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8-year follow-up . Neurol Sci . 2002;23(Suppl 2):S91–S94
  74. Lauterbach EC . The neuropsychiatry of Parkinson's disease and related disorders . Psychiatr Clin North Am . 2004;27:801–825
  75. Postuma RB , Lang AE , Massicotte-Marquez J , Montplaisir J . Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder . Neurology . 2006;66:845–851
  76. De Cock VC , Vidailhet M , Leu S , Texeira A , Apartis E , Elbaz A , et al.   Restoration of normal motor control in Parkinson's disease during REM sleep . Brain . 2007;130:450–456
  77. Barone P , Amboni M , Vitale C , Bonavita V . Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease . Neurology . 2004;63(8 Suppl 3):S35–S38
  78. Poryazova RG , Zachariev ZI . REM sleep behavior disorder in patients with Parkinson's disease . Folia Med (Plovdiv) . 2005;47:5–10
  79. Rye DB . Excessive daytime sleepiness and unintended sleep in Parkinson's disease . Curr Neurol Neurosci Rep . 2006;6:169–176
  80. Andreu N , Chale JJ , Senard JM , Thalamas C , Montastruc JL , Rascol O . L-dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers . Clin Neuropharmacol . 1999;22:15–23
  81. Frucht S , Rogers JD , Greene PE , Gordon MF , Fahn S . Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole . Neurology . 1999;52:1908–1910
  82. Gjerstad MD , Alves G , Wentzel-Larsen T , Aarsland D , Larsen JP . Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease? . Neurology . 2006;67:853–858
  83. Hogl B , Saletu M , Brandauer E , Glatzl S , Frauscher B , Seppi K , et al.   Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial . Sleep . 2002;25:905–909
  84. Adler CH , Caviness JN , Hentz JG , Lind M , Tiede J . Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease . Mov Disord . 2003;18:287–293
  85. Ondo WG , Fayle R , Atassi F , Jankovic J . Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial . J Neurol Neurosurg Psychiatry . 2005;76:1636–1639
  86. Garcia-Borreguero D , Odin P , Serrano C . Restless legs syndrome and PD: a review of the evidence for a possible association . Neurology . 2003;61(6 Suppl 3):S49–S55
  87. Rye DB . Parkinson's disease and RLS: the dopaminergic bridge . Sleep Med . 2004;5:317–328
  88. Poewe W , Hogl B . Akathisia, restless legs and periodic limb movements in sleep in Parkinson's disease . Neurology . 2004;63(8 Suppl 3):S12–S16
  89. Krishnan PR , Bhatia M , Behari M . Restless legs syndrome in Parkinson's disease: a case-controlled study . Mov Disord . 2003;18:181–185
  90. Poewe W , Hogl B . Akathisia, restless legs and periodic limb movements in sleep in Parkinson's disease . Neurology . 2004;63(8 Suppl 3):S12–S16
  91. Nomura T , Inoue Y , Nakashima K . Clinical characteristics of Restless legs syndrome in patients with Parkinson's disease . J Neurol Sci . 2006;250:39–44
  92. Ondo W , Romanyshyn J , Vuong KD , Lai D . Long-term treatment of restless legs syndrome with dopamine agonists . Arch Neurol . 2004;61:1393–1397
  93. Montplaisir J , Karrasch J , Haan J , Volc D . Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial . Mov Disord . 2006;21:1627–1635
  94. Bogan RK , Fry JM , Schmidt MH , Carson SW , Ritchie SY , TREAT RLS US Study Group  . Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial . Mayo Clin Proc . 2006;81:17–27
  95. Oertel WH , Stiasny-Kolster K , Bergtholdt B , Hallstrom Y , Albo J , Leissner L , et al.   Pramipexole RLS Study Group. Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study) . Mov Disord . 2007;22:213–219
  96. Lesage S , Hening WA . The restless legs syndrome and periodic limb movement disorder: a review of management . Semin Neurol . 2004;24:249–259
  97. Kurlan R , Richard IH , Deeley C . Medication tolerance and augmentation in restless legs syndrome: the need for drug class rotation . J Gen Intern Med . 2006;21:C1–C4
  98. Montagna P . The treatment of restless legs syndrome . Neurol Sci . 2007;28(Suppl 1):S61–S66
  99. Driver-Dunckley E , Evidente VG , Adler CH , Hillman R , Hernandez J , Fletcher G , et al.   Restless legs syndrome in Parkinson's disease patients may improve with subthalamic stimulation . Mov Disord . 2006;21:1287–1289
  100. Benarroch EE . Central neurotransmitters and neuromodulators in cardiovascular regulation . In:  Mathias CJ ,  Bannister R editor. Autonomic Failure . 4th edition. Oxford: Oxford University Press; 1999;p. 37–44
  101. Goldstein DS . Orthostatic hypotension as an early finding in Parkinson's disease . Clin Auton Res . 2006;16:46–54
  102. Kujawa K , Leurgans S , Raman R , Blasucci L , Goetz CG . Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease . Arch Neurol . 2000;57:1461–1463
  103. Etminan M , Gill S , Samii A . Comparison of the risk of adverse events with pramipexole and ropinirole in patients with Parkinson's disease: a meta-analysis . Drug Saf . 2003;26:439–444
  104. Desboeuf K , Grau M , Riche F , Fradin M , Bez J , Montastruc JL , et al.   Prevalence and costs of parkinsonian syndromes associated with orthostatic hypotension . Therapie . 2006;61:93–99
  105. Khan NL , Graham E , Critchley P , Schrag AE , Wood NW , Lees AJ , et al.   Parkin disease: a phenotypic study of a large case series . Brain . 2003;126:1279–1292
  106. Pfeiffer RF . Gastrointestinal dysfunction in Parkinson's disease . Lancet Neurol . 2003;2:107–116
  107. Kaye J , Gage H , Kimber A , Storey L , Trend P . Excess burden of constipation in Parkinson's disease: a pilot study . Mov Disord . 2006;21:1270–1273
  108. Byrne KG , Pfeiffer R , Quigley EM . Gastrointestinal dysfunction in Parkinson's disease: a report of clinical experience at a single center . J Clin Gastroenterol . 1994;19:11–16
  109. Ueki A , Otsuka M . Life style risks of Parkinson's disease: association between decreased water intake and constipation . J Neurol . 2004;251(Suppl 7):vii18–vii23
  110. Jost WH , Eckardt VF . Constipation in idiopathic Parkinson's disease . Scand J Gastroenterol . 2003;38:681–686
  111. Miller N , Noble E , Jones D , Burn D . Hard to swallow: dysphagia in Parkinson's disease . Age Ageing . 2006;35:614–618
  112. Diamond A , Jankovic J . Treatment of advanced Parkinson's disease . Expert Rev Neurother . 2006;6:1181–1197
  113. Sempere AP , Duarte J , Cabezas C , Claveria LE , Coria F . Aggravation of parkinsonian tremor by cisapride . Clin Neuropharmacol . 1995;18:76–78
  114. Winge K , Skau AM , Stimpel H , Nielsen KK , Werdelin L . Prevalence of bladder dysfunction in Parkinson's disease . Neurourol Urodyn . 2006;25:116–122
  115. Hobson P , Islam W , Roberts S , Adhiyman V , Meara J . The risk of bladder and autonomic dysfunction in a community cohort of Parkinson's disease patients and normal controls . Parkinsonism Relat Disord . 2003;10:67–71
  116. Winge K , Friberg L , Werdelin L , Nielsen KK , Stimpel H . Relationship between nigrostriatal dopaminergic degeneration, urinary symptoms, and bladder control in Parkinson's disease . Eur J Neurol . 2005;12:842–850
  117. Winge K , Werdelin LM , Nielsen KK , Stimpel H . Effects of dopaminergic treatment on bladder function in Parkinson's disease . Neurourol Urodyn . 2004;23:689–696
  118. Uchiyama T , Sakakibara R , Hattori T , Yamanishi T . Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon . Mov Disord . 2003;18:573–578
  119. Papatsoris AG , Deliveliotis C , Singer C , Papapetropoulos S . Erectile dysfunction in Parkinson's disease . Urology . 2006;67:447–451
  120. Zesiewicz TA , Helal M , Hauser RA . Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's disease . Mov Disord . 2000;15:305–308
  121. Hussain IF , Brady CM , Swinn MJ , Mathias CJ , Fowler CJ . Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension . J Neurol Neurosurg Psychiatry . 2001;71:371–374
  122. Raffaele R , Vecchio I , Giammusso B , Morgia G , Brunetto MB , Rampello L . Efficacy and safety of fixeddose oral sildenafil in the treatment of sexual dysfunction in depressed patients with idiopathic Parkinson's disease . Eur Urol . 2002;41:382–386
  123. Pohanka M , Kanovsky P , Bares M , Pulkrabek J , Rektor I . The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson's disease induced by pergolide: evidence from the results of an open, prospective, one-year trial . Parkinsonism Relat Disord . 2005;11:509–512
  124. Cannas A , Solla P , Floris G , Tacconi P , Loi D , Marcia E , et al.   Hypersexual behaviour, frotteurism and delusional jealousy in a young parkinsonian patient during dopaminergic therapy with pergolide: a rare case of iatrogenic paraphilia . Prog Neuropsychopharmacol Biol Psychiatry . 2006;30:1539–1541
  125. Weintraub D , Potenza MN . Impulse control disorders in Parkinson's disease . Curr Neurol Neurosci Rep . 2006;6:302–306
  126. Swinn L , Schrag A , Viswanathan R , Bloem BR , Lees A , Quinn N . Sweating dysfunction in Parkinson's disease . Mov Disord . 2003;18:1459–1463
  127. Schestatsky P , Valls-Sole J , Ehlers JA , Rieder CR , Gomes I . Hyperhidrosis in Parkinson's disease . Mov Disord . 2006;21:1744–1748

PII: S1873-9598(08)70024-3

doi: 10.1016/S1873-9598(08)70024-3

International Journal of Gerontology
Volume 1, Issue 2 , Pages 53-64 , June 2007

Article Tools